Fobi AI Inc. (FOBI:TSXV) has announced the signing of a significant data license agreement with Vancouver Island Brewing (VI Brewing), marking their second collaboration and enhancing the brewery's capabilities with advanced data analytics. The announcement of this new agreement builds upon the initial collaboration started on August 16, 2023, demonstrating a strengthening relationship between the two companies.
The agreement with VI Brewing will empower the brewery with Fobi's real-time analytics, allowing them to make quicker, smarter, and data-driven decisions, which are crucial in today's dynamic market. This strategic partnership both validates Fobi’s Fobi Data Exchange's impact in the beverage and liquor industry and enhances its footprint in the market, capitalizing on the trend towards data-driven business operations.
Important Disclosures:
- Fobi is a billboard sponsor of Streetwise Reports and pays SWR a monthly sponsorship fee between US$4,000 and US$5,000. In addition,Fobi has a consulting relationship with an affiliate of Streetwise Reports, and pays a monthly consulting fee between US$8,000 and US$20,000.
- As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Fobi
- James Guttman wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.
- This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.
- This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice.
For additional disclosures, please click here.